# BESREMI
> **BLA761166** · Biologics License Application · Sponsor: PHARMAESSENTIA CORP · Approved 2021-11-12
## Drug
- **FDA Application Number:** BLA761166
- **Application type:** Biologics License Application
- **Brand name:** BESREMI
- **Generic name:** ROPEGINTERFERON ALFA-2B
- **Active ingredients:** ROPEGINTERFERON ALFA-2B-NJFT
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** PHARMAESSENTIA CORP
- **Manufacturer:** PharmaEssentia USA
- **First approval:** 2021-11-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761166)
---
*AI Analytics · CC0 1.0*